NASDAQ
Global Blood Therapeutics, Inc. (GBT) has a price/fcf ratio of -7.08x as of Monday, May 25, 2026. This represents a 58.20% increase compared to its 12-month average of -16.94x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.